Summary Sucampo Pharmaceuticals Inc (Sucampo) is a biopharmaceutical company which conducts research, discovers, develops and commercializes proprietary drugs to address unmet medical needs. Its drugs are indicated for the treatment of gastrointestinal, ophthalmic, and cancer-based inflammatory disorders. Sucampo’s marketed products include Amitiza (lubiprostone), which is indicated for the treatment of chronic idiopathic constipation in adults, irritable bowel syndrome with constipation in a...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.